Nationwide Pharmaceutical Litigation and Wrongful Death Lawyers

The mortality rates for those with HIV-PML have fallen dramatically from approximately 90 percent to around 50 percent according to most reports.   For non-AIDS individuals with PML, the prognosis remains grim; the disease usually lasts for months and 80 percent die within the first 6 months, although spontaneous improvement has been reported.  Those who survive PML can be left with severe neurological disabilities.

RAPTIVA (EFALIZUMAB) LAWSUITS

If you or somebody you know took Raptiva (efalizumab) and developed progressive multifocal leukoencephalopathy (PML), you should contact us immediately.

Blizzard, McCarthy & Nabers is currently active in litigating these cases against the makers of Raptiva. Please use the form below to contact us for a free case evaluation or call toll free 24 hrs/day (866) 879-3040. We look forward to helping you.

Currently, the best available therapy is reversal of the immune-deficient state. This can sometimes be accomplished by alteration of chemotherapy or immunosuppression (even if it means losing non-vital transplanted organs). In the case of HIV-associated PML, immediately beginning anti-retroviral therapy will benefit most individuals.

RAPTIVA (EFALIZUMAB) LAWSUITS

If you or somebody you know took Raptiva (efalizumab) and developed progressive multifocal leukoencephalopathy (PML), you should contact us immediately.

Blizzard, McCarthy & Nabers is currently active in litigating these cases against the makers of Raptiva. Please use the form below to contact us for a free case evaluation or call toll free 24 hrs/day (866) 879-3040. We look forward to helping you.

Progressive multifocal leukoencephalopathy (PML) is caused by the reactivation of a common virus in the central nervous system of immune-compromised individuals.  Polyomavirus JC (often called JC virus) is carried by a majority of people and is harmless except among those with lowered immune defenses.  The disease occurs, rarely, in organ transplant patients; people undergoing chronic corticosteroid or immunosuppressive therapy; and individuals with cancer, such as Hodgkin’s disease, lymphoma, and sarcoidosis.  PML is most common among individuals with acquired immune deficiency syndrome (AIDS). Studies estimate that prior to effective antiretroviral therapy, as many as 5 percent of people with AIDS eventually developed PML. For them, the disease was most often rapidly fatal.

RAPTIVA (EFALIZUMAB) LAWSUITS

If you or somebody you know took Raptiva (efalizumab) and developed progressive multifocal leukoencephalopathy (PML), you should contact us immediately.

Blizzard, McCarthy & Nabers is currently active in litigating these cases against the makers of Raptiva. Please use the form below to contact us for a free case evaluation or call toll free 24 hrs/day (866) 879-3040. We look forward to helping you.

Europe’s main medical regulator on Thursday recommended that the psoriasis drug Raptiva be withdrawn from the European market while the U.S. Food and Drug Administration separately warned that use of the drug poses the risk of developing a rare and often fatal brain infection known as progressive multifocal leukoencephalopathy, or PML.

Read More: http://online.wsj.com/article/SB123506249600223995.html

RAPTIVA (EFALIZUMAB) LAWSUITS

If you or somebody you know took Raptiva (efalizumab) and developed progressive multifocal leukoencephalopathy (PML), you should contact us immediately.

Blizzard, McCarthy & Nabers is currently active in litigating these cases against the makers of Raptiva. Please use the form below to contact us for a free case evaluation or call toll free 24 hrs/day (866) 879-3040. We look forward to helping you.

The FDA said today that patients taking the Genentech drug Raptiva are at risk of developing a potentially fatal condition known as PML, or progressive multifocal leukoencephalopathy.

The drug’s label already carried a warning about this possibility. But last week, Genentech sent a letter to alert doctors that a third case of PML had been confirmed in a Raptiva patient, following two other cases reported last fall.

The EMEA, Europe’s answer to the FDA, said today that the risks of Raptiva now outweigh the benefits, and the drug shouldn’t be prescribed to new patients. (A unit of Merck KGaA sells the drug in Europe.)

Read More: http://blogs.wsj.com/health/2009/02/19/new-warning-on-genentechs-raptiva-what-is-pml-anyway/

RAPTIVA (EFALIZUMAB) LAWSUITS

If you or somebody you know took Raptiva (efalizumab) and developed progressive multifocal leukoencephalopathy (PML), you should contact us immediately.

Blizzard, McCarthy & Nabers is currently active in litigating these cases against the makers of Raptiva. Please use the form below to contact us for a free case evaluation or call toll free 24 hrs/day (866) 879-3040. We look forward to helping you.

European regulators have suspended sales of Genentech’s psoriasis drug Raptiva after reports that three patients taking the drug have died of a rare brain infection.

Rapitiva is known to risk four cases of a deadly brain infection along with the skin-clearing treatment, according to officials of the US Food and Drug Administration (FDA).  The rare brain infection linked to the use of Raptiva is progressive multifocal leukoencephalopathy (PML).

Raptiva (efalizumab) Lawsuits

If you or somebody you know took Raptiva (efalizumab) and developed progressive multifocal leukoencephalopathy (PML), you should contact us immediately.

Blizzard, McCarthy & Nabers is currently active in litigating these cases against the makers of Raptiva. Please use the form below to contact us for a free case evaluation or call toll free 24 hrs/day (866) 879-3040. We look forward to helping you.

ETHEX Corporation has initiated a nationwide recall of Metoprolol Succinate because they may have been manufactured under conditions that did not sufficiently comply with current Good Manufacturing Practices and more importantly, due to defects found, including oversized tablets delivering higher than labeled doses.

The Metoprolol Succinate recall includes the following products:

• Metoprolol Succinate ER Tablets, 50mg (58177-369-04, 369-09 & 369-11)
• Metoprolol Succinate ER Tablets, 100mg (58177-368-04, 368-09 & 368-11)
• Metoprolol Succinate ER Tablets, 25mg (58177-293-04, 293-09 & 293-11)
• Metoprolol Succinate ER Tablets, 200mg (58177-358-04, 358-09 & 358-11)

Drug Recall List: In addition, the company has also recalled over 125 other drugs and/or product numbers.  To view the entire list of recalled drugs from ETHEX Corporation, please click the following link: ETHEX Recall List

Free Metoprolol Succinate Recall Lawsuit Review

Important: If you or someone you know has become sick after taking Metoprolol Succinate, you should seek medical attention immediately by visiting a qualified medical professional or by dialing 911.

After you have received appropriate medical attention, you should contact us for a Free Case Evaluation. You may be entitled to compensation for your injuries and we can help.

ETHEX Corporation has initiated a nationwide recall of Hydromorphone HCl because they may have been manufactured under conditions that did not sufficiently comply with current Good Manufacturing Practices and more importantly, due to defects found, including oversized tablets delivering higher than labeled doses.

The Hydromorphone HCl recall includes the following products:

Hydromorphone HCl Tablets, 2mg (58177-620-04 & 620-11) 
Hydromorphone HCl Tablets, 4mg (58177-621-04 & 621-11)
Hydromorphone HCl Tablets, 8mg (58177-449-04)

Drug Recall List: In addition, the company has also recalled over 125 other drugs and/or product numbers.  To view the entire list of recalled drugs from ETHEX Corporation, please click the following link: ETHEX Recall List

Important: If you or someone you know has become sick after taking Hydromorphone HCl, you should seek medical attention immediately by visiting a qualified medical professional or by dialing 911.

Free Hydromorphone HCl Recall Lawsuit Review

After you have received appropriate medical attention, you should contact us. You may be entitled to compensation for your injuries and we can help.

ETHEX Corporation has initiated a nationwide recall of Tri-Vent because they may have been manufactured under conditions that did not sufficiently comply with current Good Manufacturing Practices and more importantly, due to defects found, including oversized tablets delivering higher than labeled doses.

The Tri-Vent recall includes the following products:

Tri-Vent DM Syrup (58177-925-07)
Tri-Vent DPC Liquid (58177-923-07)
Tri-Vent HC Liquid (58177-920-07)

Drug Recall List: In addition, the company has also recalled over 125 other drugs and/or product numbers.  To view the entire list of recalled drugs from ETHEX Corporation, please click the following link: ETHEX Recall List

Important: If you or someone you know has become sick after taking Tri-Vent, you should seek medical attention immediately by visiting a qualified medical professional or by dialing 911.

Free Tri-Vent Recall Lawsuit Review

After you have received appropriate medical attention, you should contact us. You may be entitled to compensation for your injuries and we can help.

ETHEX Corporation has initiated a nationwide recall of Pseudovent because they may have been manufactured under conditions that did not sufficiently comply with current Good Manufacturing Practices and more importantly, due to defects found, including oversized tablets delivering higher than labeled doses.

The Pseudovent recall includes the following products:

Pseudovent 400 Capsules (58177-096-04)
Pseudovent Capsules (58177-045-04)
Pseudovent PED Capsules (58177-046-04)

Drug Recall List: In addition, the company has also recalled over 125 other drugs and/or product numbers.  To view the entire list of recalled drugs from ETHEX Corporation, please click the following link: ETHEX Recall List

Important: If you or someone you know has become sick after taking Pseudovent, you should seek medical attention immediately by visiting a qualified medical professional or by dialing 911.

Free Pseudovent Recall Lawsuit Review

After you have received appropriate medical attention, you should contact us. You may be entitled to compensation for your injuries and we can help.